A couple seeks counseling about the risk of their child developing a recessive disorder. The woman is affected and upon further testing it is determined that the man is a carrier. Which of the following is true?

Choice A reason: Beta blockers are commonly used to treat cardiac dysrhythmias (irregular heartbeats). They work by blocking the effects of adrenaline on the heart, which helps to reduce the heart rate and regulate the rhythm. This makes beta blockers effective in managing conditions such as atrial fibrillation, ventricular arrhythmias, and supraventricular tachycardia.

Choice B reason: Hypotension (low blood pressure) is not typically treated with beta blockers. In fact, beta blockers can sometimes lower blood pressure, so they are usually avoided in patients with pre-existing hypotension. Instead, other medications or treatments are used to manage low blood pressure.

Choice C reason: Hypothyroidism (underactive thyroid) is not treated with beta blockers. The primary treatment for hypothyroidism is thyroid hormone replacement therapy, usually with levothyroxine. Beta blockers do not address the underlying issue of thyroid hormone deficiency and are not used in the management of this condition.

Choice D reason: Beta blockers are used to treat heart failure, particularly in patients with systolic heart failure. They help to reduce the workload on the heart, improve heart function, and decrease the risk of hospitalization and mortality. By slowing the heart rate and reducing the force of contraction, beta blockers can help to manage symptoms and improve outcomes in heart failure patients.

Choice E reason: Beta blockers are used to treat stage fright (performance anxiety) because they help to control physical symptoms of anxiety, such as rapid heart rate, trembling, and sweating. By blocking the effects of adrenaline, beta blockers can help individuals feel calmer and more composed during stressful situations, such as public speaking or performing in front of an audience.

Choice A reason: Warfarin does not primarily prevent platelet aggregation. It is an anticoagulant that inhibits the synthesis of vitamin K-dependent clotting factors, which are necessary for blood clot formation. Although it affects the clotting process, it does not have a direct impact on platelets.

Choice B reason: Heparin does not have a longer half-life compared to warfarin. In fact, heparin has a relatively short half-life, which allows for rapid adjustments in dosing. This characteristic makes it suitable for acute management of conditions like deep vein thrombosis (DVT), where immediate anticoagulation is necessary.

Choice C reason: Heparin does not necessarily have fewer adverse effects compared to warfarin. Both medications have potential side effects and risks. Heparin can cause bleeding, heparin-induced thrombocytopenia (HIT), and other complications, while warfarin also carries a risk of bleeding and requires careful monitoring due to its interactions with foods and other medications.

Choice D reason: The onset of warfarin is slower than heparin. Heparin works rapidly to anticoagulate the blood and is often used for immediate management of conditions like DVT. Warfarin, on the other hand, takes several days to reach its full anticoagulant effect as it gradually reduces the levels of clotting factors. Therefore, patients are typically started on heparin for immediate effect and then transitioned to warfarin for long-term anticoagulation.